Xiaoqin W. Li
Jiefang Road
Zhenjiang, 212001, China
Zhenjiang, 212001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Risk of interstitial lung disease in non-small cell lung cancer treated with EGFR-TKI: a real-world pharmacovigilance study.
Journal: Frontiers in pharmacology
Published: June 24, 2025
Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review.
Journal: Frontiers in immunology
Published: October 09, 2024
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: September 29, 2024
EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer.
Journal: Technology in cancer research & treatment
Published: August 21, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.
Journal: Signal transduction and targeted therapy
Published: December 20, 2023
m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy.
Journal: Frontiers in immunology
Published: October 22, 2023
A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
Journal: Journal of translational medicine
Published: October 16, 2023
Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer.
Journal: Frontiers in immunology
Published: September 06, 2023
DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1α.
Journal: Cell death & disease
Published: May 16, 2023
HDAC-an important target for improving tumor radiotherapy resistance.
Journal: Frontiers in oncology
Published: March 25, 2023
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
Journal: Lipids in health and disease
Published: February 12, 2023
Last Updated: 09/26/2026